Dr. Andrew Mendlowitz is a Visiting Fellow from Canada collaborating with the Viral Hepatitis Clinical Research Program on economic evaluations related to hepatitis C virus testing and subsequent treatment strategies across priority settings. Andrew is a Postdoctoral Fellow at the Viral Hepatitis Care Network (VIRCAN)/Toronto Centre for Liver Disease, University Health Network in Toronto, Ontario, Canada. Andrew completed his doctoral studies in Health Services Research – Health Technology Assessment at the University of Toronto. He also holds a Master of Biotechnology from the University of Toronto. Andrew’s research expertise is in decision modeling, use of administrative health data, methods for economic evaluations, and health technology assessment. His research is focused on generating evidence to inform viral hepatitis elimination efforts.
